Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings
Marta Epeldegui(University of California, Los Angeles), Mina C. Hosseinipour, Larry Magpantay(University of California, Los Angeles), Thomas Campbell(University of Colorado Anschutz Medical Campus), Deborah Langat(Kenya Medical Research Institute), Catherine Godfrey(United States Department of State), Margaret Borok(University of Zimbabwe), Wadzanai Samaneka(University of Zimbabwe), Naftali Busakhala(Moi University), Susan E. Krown(Memorial Sloan Kettering Cancer Center), Jeannette Y. Lee(University of Arkansas at Little Rock), Brenda Hoagland(Fundação Oswaldo Cruz), Noluthando Mwelase(University of the Witwatersrand), Mulinda Nyirenda(University of Malawi), Otoniel Martı́nez-Maza(University of California, Los Angeles), Rosie Mngqibisa, Di Chang(University of Arkansas for Medical Sciences), Minhee Kang(Cancer Research And Biostatistics), Aggrey Bukuru(Joint Clinical Research Centre), Cecilia Kanyama
Cited by 15
Related Papers
Kaposi sarcoma
|Nature Reviews Disease Primers|2019|707
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
|New England Journal of Medicine|2021|548
Alterations in the Gut Microbiota Associated with HIV-1 Infection
|Cell Host & Microbe|2013|508